Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1.

Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1. Br J Haematol. 2019 04; 185(2):374-377.

View in: PubMed

subject areas

Adolescent
Adolescent
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Burkitt Lymphoma
Burkitt Lymphoma
Central Nervous System Neoplasms
Central Nervous System Neoplasms
Child
Child
Female
Female
Humans
Humans
Immunotherapy
Immunotherapy
Injections, Spinal
Injections, Spinal
Kaplan-Meier Estimate
Kaplan-Meier Estimate
Lymphoma, B-Cell
Lymphoma, B-Cell
Male
Male
Rituximab
Rituximab
Treatment Outcome
Treatment Outcome

authors with profiles

John Kimble Frazer